newsfilter
← Latest News
PR Newswire·

Inhibrx Announces Participation in Upcoming Scientific Conferences

SAN DIEGO, Oct. 13, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (NASDAQ:INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel